Cargando…
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer
Even though gene amplification or protein overexpression occurs in approximately one-fifth of all breast cancers, the discovery of HER2 has, nevertheless, had profound implications for the disease. Indeed, the characterization of the receptor resulted in a number of significant advances. Structurall...
Autores principales: | Salkeni, Mohamad Adham, Rizvi, Wajeeha, Hein, Kyaw, Higa, Gerald M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481821/ https://www.ncbi.nlm.nih.gov/pubmed/34602823 http://dx.doi.org/10.2147/BCTT.S288344 |
Ejemplares similares
-
Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Salkeni, Mohamad Adham, et al.
Publicado: (2017) -
Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer
por: Basade, M., et al.
Publicado: (2018) -
Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005) -
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
por: Hashmi, Atif Ali, et al.
Publicado: (2018) -
HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007)